Chemistry:LY-215,840

From HandWiki
Short description: Chemical compound
LY-215,840
LY-215840 structure.png
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
Chemical and physical data
FormulaC24H33N3O2
Molar mass395.547 g·mol−1
3D model (JSmol)

LY-215,840 is an ergoline derivative drug developed by Eli Lilly, which acts as a potent and selective antagonist at the serotonin 5-HT2 and 5-HT7 receptors. It has anti-hypertensive and muscle relaxant effects in animal studies.[1][2][3][4][5][6][7][8]

References

  1. "LY215840, a potent 5-hydroxytryptamine (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2 receptors and delays occlusion in a rabbit model of thrombosis". The Journal of Pharmacology and Experimental Therapeutics 261 (1): 202–8. April 1992. PMID 1560366. 
  2. "LY215840, a high-affinity 5-HT7 receptor ligand, blocks serotonin-induced relaxation in canine coronary artery". The Journal of Pharmacology and Experimental Therapeutics 277 (3): 1560–6. June 1996. PMID 8667223. 
  3. "Pharmacological evidence for the 5-HT7 receptor mediating smooth muscle relaxation in canine cerebral arteries". British Journal of Pharmacology 127 (3): 609–16. June 1999. doi:10.1038/sj.bjp.0702580. PMID 10401550. 
  4. "Role of 5-HT(1A) and 5-HT(7) receptors in the facilitatory response induced by 8-OH-DPAT on learning consolidation". Behavioural Brain Research 121 (1–2): 21–8. June 2001. doi:10.1016/S0166-4328(00)00378-8. PMID 11275281. 
  5. "Activation of Erk mitogen-activated protein kinase proteins by vascular serotonin receptors". Journal of Cardiovascular Pharmacology 38 (4): 539–51. October 2001. doi:10.1097/00005344-200110000-00006. PMID 11588524. 
  6. "Activation of 5-HT(7) receptor in rat glomerulosa cells is associated with an increase in adenylyl cyclase activity and calcium influx through T-type calcium channels". Endocrinology 143 (5): 1748–60. May 2002. doi:10.1210/endo.143.5.8817. PMID 11956157. 
  7. "Involvement of 5-HT(2A/2B/2C) receptors on memory formation: simple agonism, antagonism, or inverse agonism?". Cellular and Molecular Neurobiology 22 (5–6): 675–88. December 2002. doi:10.1023/A:1021800822997. PMID 12585687. 
  8. "Pharmacological profile of the 5-HT-induced inhibition of cardioaccelerator sympathetic outflow in pithed rats: correlation with 5-HT1 and putative 5-ht5A/5B receptors". British Journal of Pharmacology 140 (4): 725–35. October 2003. doi:10.1038/sj.bjp.0705489. PMID 14504136.